Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 13, 2022
Biofrontera Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Biofrontera Pharma’s cGMP laboratory in Leverkusen, Germany, as a contract laboratory for batch control and stability testing of Ameluz® (aminolevulinic acid ...
read more
Wednesday, April 13, 2022
ApiJect Systems, Corp. announced the launch of the ApiJect Technology Development Center in greater Orlando, FL.
read more
BIOVECTRA has broken ground on a cutting-edge facility that will manufacture mRNA vaccines and therapeutics starting in 2023.
read more
Heat Biologics, Inc. is changing the name of the company to NightHawk Biosciences, Inc., effective May 3, 2022, to better reflect the Company’s evolution, including expansion of its therapeutic pipeline, the vertical integration of capabilities from ...
read more
Catalent announced a multi-year $350 million investment at its facility in Bloomington, Indiana, to expand biologics drug substance and drug product manufacturing capabilities. The project will serve the industry’s robust biologics pipeline across ...
read more
Lonza and Integral Molecular announced a strategy to offer complementary expertise to their respective customers to better assess the risks of off-target binding of biologic drug candidates.
read more
Inotiv, Inc. announced the acquisition of Histion, LLC, effective April 25, 2022. The acquisition is a strategic element of the company’s expansion of its specialized pathology services.
read more
ProteoNic and NecstGen announced a partnership for the development of improved viral vector manufacturing for gene therapy applications.
read more
Wednesday, April 27, 2022
Biopharmaceutical contract development and manufacturing organization (CDMO) Scorpion Biological Services (Scorpion) today announced a planned development partnership with a private developer, the State of Kansas, and local and university affiliates,...
read more
Belgium-based AARDEX® Group, the leader in measuring and managing medication adherence in clinical trials today announced a strategic partnership with etectRx, Inc. This new collaboration combines etectRx’s ingestible event marker, the ID-Cap™ System...
read more
Grand River Aseptic Manufacturing has signed a multi-year contract with the U.S. Department of Health and Human Services and the U.S. Department of Defense. Under the agreement, GRAM will invest $160 million and receive $120 million from the U.S. ...
read more
Astorg and International Chemical Investors Group (ICIG) have signed a binding agreement whereby Astorg will acquire CordenPharm from ICIG. As part of the transaction, the founders will take the opportunity to reinvest as partners with Astorg.
read more
Avantor, Inc. announced it will create a new manufacturing and distribution hub in Singapore by integrating its existing distribution facility with new manufacturing operations.
read more
Societal CDMO, Inc. has entered into a three-year manufacturing and supply agreement with InfectoPharm for Ritalin LA® capsules (methylphenidate hydrochloride extended-release capsules) in Europe.
read more
EVONETIX, a synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has been granted a European patent covering its unique Binary Assembly method for gene synthesis.
read more